Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Torguson

Showing results (321-330 of 378) with videos related to

Pageof 38
Sort By:
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
The American Journal of Cardiology|July 7, 2009
Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantationGilles Lemesle, Laurent Bonello, Axel de Labriolle, et al.
The American Journal of Cardiology|March 31, 2009
Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent eraProbal Roy, Axel de Labriolle, Nicholas Hanna, et al.
Circulation|February 24, 2006
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stentsPramod K Kuchulakanti, William W Chu, Rebecca Torguson, et al.
The American Journal of Cardiology|February 24, 2009
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stentsMichael A Gaglia, Daniel H Steinberg, Tina L Pinto Slottow, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Insurance type influences the use of drug-eluting stentsMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2010
Does on- versus off-hours presentation impact in-hospital outcomes of ST-segment elevation myocardial infarction patients transferred to a tertiary care center?Manuel A Gonzalez, Itsik Ben-Dor, Kohei Wakabayashi, et al.
American Heart Journal|August 10, 2016
Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacementSarkis Kiramijyan, Marco A Magalhaes, Edward Koifman, et al.
The American Journal of Cardiology|September 22, 2007
Impact of in-stent restenosis on death and myocardial infarctionDaniel H Steinberg, Tina L Pinto Slottow, Ashesh N Buch, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 20, 2017
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trialRon Waksman, Guy N Piegari, Ameer Kabour, et al.
Pageof 38

Showing results (321-330 of 378) with videos related to

Sort By:
Pageof 38
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
The American Journal of Cardiology|July 7, 2009
Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantationGilles Lemesle, Laurent Bonello, Axel de Labriolle, et al.
The American Journal of Cardiology|March 31, 2009
Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent eraProbal Roy, Axel de Labriolle, Nicholas Hanna, et al.
Circulation|February 24, 2006
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stentsPramod K Kuchulakanti, William W Chu, Rebecca Torguson, et al.
The American Journal of Cardiology|February 24, 2009
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stentsMichael A Gaglia, Daniel H Steinberg, Tina L Pinto Slottow, et al.
JACC. Cardiovascular Interventions|July 24, 2010
Insurance type influences the use of drug-eluting stentsMichael A Gaglia, Rebecca Torguson, Zhenyi Xue, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2010
Does on- versus off-hours presentation impact in-hospital outcomes of ST-segment elevation myocardial infarction patients transferred to a tertiary care center?Manuel A Gonzalez, Itsik Ben-Dor, Kohei Wakabayashi, et al.
American Heart Journal|August 10, 2016
Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacementSarkis Kiramijyan, Marco A Magalhaes, Edward Koifman, et al.
The American Journal of Cardiology|September 22, 2007
Impact of in-stent restenosis on death and myocardial infarctionDaniel H Steinberg, Tina L Pinto Slottow, Ashesh N Buch, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 20, 2017
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trialRon Waksman, Guy N Piegari, Ameer Kabour, et al.
Pageof 38